Please note: We are currently experiencing some performance issues across the site, and some pages may be slow to load. We are working on restoring normal service soon. Importing new articles from Word documents is also currently unavailable. We apologize for any inconvenience.

Hui Zhang

and 4 more

Background: Laparoscopic liver resection (LLR) has not been widely accepted for recurrent liver cancer (RLC). This study aims to conduct a systematic review of the current literature for determining LLR effectiveness and safety for patients with RLC. Methods: Before April 2022, a comprehensive literature search was undertaken in Web of Science, PubMed, and Embase relied on a specified search strategy for eligible propensity score matching (PSM) studies comparing LLR or OLR. Meta-analysis of operative times, duration of stay, mortality, blood loss, overall survival rate, blood transfusion, recurrence-free survival rate, and overall complications was undertaken using a random/fixed-effects model. Results: Eight PSM studies of LLR versus OLR were incorporated, including 1128 patients. The current meta-analysis revealed nonsignificant variations between the two groups in overall survival rate, operation time, blood transfusion, mortality, overall complications, and long-term recurrence-free survival rate. Alternatively, when LLR is compared to OLR, LLR results in lower blood loss (p=0.002) and a shorter hospitalization (p=0.04). Conclusion: Although both techniques appear equal, LLR seems to have certain advantages over OLR. Notably, the evidence quality is generally confined to cohort studies, necessitating the performance of a high-quality randomized trial that compares both approaches. Keywords: Laparoscopic surgery, Liver resection, Recurrent liver cancer, Propensity score matching, Meta-analysis.